ArticlePloS one2026
Compact high power, medium energy electron accelerator for treatment of per- and polyfluoroalkyl contamination in water.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electron beam water treatment (EBWT) is a promising approach for remediating water contaminated with per- and polyfluoroalkyl substances (PFAS). In this study, we assess the feasibility of using a compact, high-average-power superconducting radio-frequency (SRF) photoinjector as a source for delivering the electron beam parameters required to initiate PFAS degradation. Our goals are twofold: first, to determine whether such a system can achieve the necessary dose and dose rate through sufficient beam energy and power; and second, to establish an experimental platform for investigating how different beam conditions affect degradation pathways. We envision a compact and mobile SRF-based accelerator that can be deployed at contamination hotspots - such as the former Berlin airport Tegel - offering significantly faster and potentially more effective treatment than conventional remediation methods. Based on theoretical analysis and computational modeling, we identify the SRF photoinjector at Helmholtz-Zentrum Berlin (HZB) as a suitable R&D platform. To support experimental validation, we developed a proof-of-concept in-air beamline optimized for balancing dose deposition and thermal management. This setup will enable the systematic study of key operational parameters, including dose rate, energy deposition, and thermal stability, under controlled beam conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.